Venus Medtech (Hangzhou) Inc. announced audited consolidated earnings results for the year ended December 31, 2020. For the year, the company reported revenue was RMB 276,047,000 against RMB 233,272,000 a year ago. Loss for the year was RMB 182,868,000 against RMB 380,765,000 a year ago. Basic and diluted loss per share attributable to ordinary equity holders of the parent was RMB 0.45 against RMB 1.22 a year ago.